Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature.
Spiezia AL, Carotenuto A, Iovino A, Moccia M, Gastaldi M, Iodice R, Tedeschi E, Petracca M, Lavorgna L, d'Ambrosio A, Brescia Morra V, Lanzillo R. Spiezia AL, et al. Among authors: lanzillo r. Int J Mol Sci. 2022 Nov 23;23(23):14559. doi: 10.3390/ijms232314559. Int J Mol Sci. 2022. PMID: 36498887 Free PMC article. Review.
Multiple sclerosis and headache co-morbidity. A case-control study.
Vacca G, Marano E, Brescia Morra V, Lanzillo R, De Vito M, Parente E, Orefice G. Vacca G, et al. Among authors: lanzillo r. Neurol Sci. 2007 Jun;28(3):133-5. doi: 10.1007/s10072-007-0805-1. Epub 2007 Jun 30. Neurol Sci. 2007. PMID: 17603764
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.
Lavorgna L, Bonavita S, Ippolito D, Lanzillo R, Salemi G, Patti F, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, d'Ambrosio A, Bresciamorra V, Savettieri G, Zappia M, Alfano B, Gallo A, Simone I, Tedeschi G. Lavorgna L, et al. Among authors: lanzillo r. Mult Scler. 2014 Feb;20(2):220-6. doi: 10.1177/1352458513494958. Epub 2013 Jul 9. Mult Scler. 2014. PMID: 23838177
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).
Clerico M, Schiavetti I, De Mercanti SF, Piazza F, Gned D, Brescia Morra V, Lanzillo R, Ghezzi A, Bianchi A, Salemi G, Realmuto S, Sola P, Vitetta F, Cavalla P, Paolicelli D, Trojano M, Sormani MP, Durelli L. Clerico M, et al. Among authors: lanzillo r. JAMA Neurol. 2014 Aug;71(8):954-60. doi: 10.1001/jamaneurol.2014.1200. JAMA Neurol. 2014. PMID: 24977406 Clinical Trial.
247 results